314 related articles for article (PubMed ID: 9409235)
21. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.
Graf K; Xi XP; Yang D; Fleck E; Hsueh WA; Law RE
Hypertension; 1997 Jan; 29(1 Pt 2):334-9. PubMed ID: 9039124
[TBL] [Abstract][Full Text] [Related]
22. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
Rossi MJ; Chegini N; Masterson BJ
Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
[TBL] [Abstract][Full Text] [Related]
23. Porphyromonas gingivalis reduces mitogenic and chemotactic responses of human periodontal ligament cells to platelet-derived growth factor in vitro.
Matsuda N; Takemura A; Taniguchi S; Amano A; Shizukuishi S
J Periodontol; 1996 Dec; 67(12):1335-41. PubMed ID: 8997682
[TBL] [Abstract][Full Text] [Related]
24. Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase.
Kim TJ; Han HJ; Hong SS; Hwang JH; Hwang BY; Yoo HS; Jin YR; Lee JJ; Yu JY; Lee KH; Kang BW; Yun YP
Biol Pharm Bull; 2007 Apr; 30(4):805-9. PubMed ID: 17409526
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of human smooth muscle cell proliferation by thrombin involves increased synthesis of platelet-derived growth factor.
Bydlowski SP; Pares MM; Soares RP; Lopes AA
Chest; 1998 Jul; 114(1):236-40. PubMed ID: 9674475
[TBL] [Abstract][Full Text] [Related]
26. Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cells.
Kappert K; Caglayan E; Bäumer AT; Südkamp M; Fätkenheuer G; Rosenkranz S
AIDS; 2004 Feb; 18(3):403-11. PubMed ID: 15090791
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation.
Bornfeldt KE; Raines EW; Graves LM; Skinner MP; Krebs EG; Ross R
Ann N Y Acad Sci; 1995 Sep; 766():416-30. PubMed ID: 7486687
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells.
El Mabrouk M; Singh A; Touyz RM; Schiffrin EL
Life Sci; 2000 Aug; 67(13):1613-23. PubMed ID: 10983855
[TBL] [Abstract][Full Text] [Related]
29. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways.
Iijima K; Yoshizumi M; Hashimoto M; Akishita M; Kozaki K; Ako J; Watanabe T; Ohike Y; Son B; Yu J; Nakahara K; Ouchi Y
Circulation; 2002 May; 105(20):2404-10. PubMed ID: 12021228
[TBL] [Abstract][Full Text] [Related]
30. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
31. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
Ranganna K; Joshi T; Yatsu FM
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2273-83. PubMed ID: 7489253
[TBL] [Abstract][Full Text] [Related]
32. Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-alpha.
Osornio-Vargas AR; Lindroos PM; Coin PG; Badgett A; Hernandez-Rodriguez NA; Bonner JC
Am J Physiol; 1996 Jul; 271(1 Pt 1):L93-9. PubMed ID: 8760137
[TBL] [Abstract][Full Text] [Related]
33. Enhancing effect of platelet-derived growth factors on migration of corneal endothelial cells.
Iguchi I; Kamiyama K; Wang X; Kita M; Imanishi J; Yamaguchi N; Sotozono C; Kinoshita S
Cornea; 1995 Jul; 14(4):365-71. PubMed ID: 7671608
[TBL] [Abstract][Full Text] [Related]
34. Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses.
Rolny C; Spillmann D; Lindahl U; Claesson-Welsh L
J Biol Chem; 2002 May; 277(22):19315-21. PubMed ID: 11912193
[TBL] [Abstract][Full Text] [Related]
35. Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF.
Ferns GA; Sprugel KH; Seifert RA; Bowen-Pope DF; Kelly JD; Murray M; Raines EW; Ross R
Growth Factors; 1990; 3(4):315-24. PubMed ID: 2175209
[TBL] [Abstract][Full Text] [Related]
36. PDGF-BB triggered cytoplasmic calcium responses in cells with endogenous or stably transfected PDGF beta-receptors.
Ridefelt P; Yokote K; Claesson-Welsh L; Siegbahn A
Growth Factors; 1995; 12(3):191-201. PubMed ID: 8619925
[TBL] [Abstract][Full Text] [Related]
37. Mitogens for adult rat aortic vascular smooth muscle cells in serum-free primary culture.
Grainger DJ; Witchell CM; Weissberg PL; Metcalfe JC
Cardiovasc Res; 1994 Aug; 28(8):1238-42. PubMed ID: 7954627
[TBL] [Abstract][Full Text] [Related]
38. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
Spacey GD; Uings IJ; Slater M; Hirst S; Bonser RW
Biochem Pharmacol; 1998 Feb; 55(3):261-71. PubMed ID: 9484791
[TBL] [Abstract][Full Text] [Related]
39. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
Campbell M; Trimble ER
Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231
[TBL] [Abstract][Full Text] [Related]
40. The chemotactic response to PDGF-BB: evidence of a role for Ras.
Kundra V; Anand-Apte B; Feig LA; Zetter BR
J Cell Biol; 1995 Aug; 130(3):725-31. PubMed ID: 7622571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
